|
|
|
|
Dobutamine
|
| |
|
| |
Dobutamine is a sympathomimetic drug used in the treatment of heart failure and cardiogenic shock. Its primary mechanism is direct stimulation of ß1 receptors of the sympathetic nervous system. It was developed by a laboratory led by Dr. Ronald Tuttle at Eli Lilly and Company.
tamine is used to treat acute but potentially reversible heart failure, such as cardiac surgery or cases of septic or cardiogenic shock, on the basis of its positive inotropic action.
Dobutamine can be used in cases of congestive heart failure to increase cardiac output.

Discussion
Ask a question about 'Dobutamine'
Start a new discussion about 'Dobutamine'
Answer questions from other users
|
Encyclopedia
Dobutamine is a sympathomimetic drug used in the treatment of heart failure and cardiogenic shock. Its primary mechanism is direct stimulation of ß1 receptors of the sympathetic nervous system. It was developed by a laboratory led by Dr. Ronald Tuttle at Eli Lilly and Company.
Use
Dobutamine is used to treat acute but potentially reversible heart failure, such as cardiac surgery or cases of septic or cardiogenic shock, on the basis of its positive inotropic action.
Dobutamine can be used in cases of congestive heart failure to increase cardiac output. It is indicated when parenteral therapy is necessary for inotropic support in the short-term treatment of patients with cardiac decompensation due to depressed contractility, which could be the result of either organic heart disease or cardiac surgical procedures. It is not useful in ischemic heart disease because it increases heart rate and thus increases myocardial oxygen demand.
Pharmacology
Dobutamine is a direct-acting agent whose primary activity results from stimulation of the ß1-adrenoceptors of the heart, increasing contractility and cardiac output. Since it does not act on dopamine receptors to induce the release of norepinephrine (another a1 agonist), dobutamine is less prone to induce hypertension than is dopamine. Arrhythmogenic and vasodilative effects are negligible.
Dobutamine is predominantly a ß1-adrenergic agonist, with weak ß2 activity, and a1 selective activity, although it is used clinically in cases of cardiogenic shock for its ß1 inotropic effect in increasing heart contractility and cardiac output. Dobutamine is administered as a racemic mixture consisting of both (+) and (-) isomers, and the (+) isomer is a potent ß1 agonist while the (-) isomer is a a1 agonist. Dobutamine also has mild ß2 agonist activity.
Side effects Primary side effects include those commonly seen for ß1 active sympathomimetics, such as hypertension, angina, arrhythmia, and tachycardia.
|
| |
|
|